Fig. 8From: Mesoporous silica nanotechnology: promising advances in augmenting cancer theranosticsStrategies to develop drug-loaded MSN platforms with specific biomarker recognition to trigger responses for therapeutic activity or enhancing imaging capabilitiesBack to article page